Federal Register / Vol. 75, No. 220 / Tuesday, November 16, 2010 / Notices 70007 

may include adverse acute and chronic 

health conditions, primarily respiratory 

and dermal, that may be associated with 

their exposures. CDC plans to conduct 

a scientifically valid environmental 

epidemiologic study to assess the 

potential adverse health effects among 

children. 

Plans involve a two-year Feasibility 

Study to investigate the association 

between exposure to temporary housing 

units and health conditions and to 

assess the practicality of conducting a 

larger longitudinal study. If certain 

feasibility objectives are met, such as 

identifying a sufficient number of 

eligible participants, a 6-year Full Study 

will be conducted following the same 

study design as the Feasibility Study. 

The Feasibility Study will be 

conducted in the states of Louisiana and 

Mississippi. The study will assess the 

potential health impacts from exposures 

to various indoor pollutants (e.g., 

formaldehyde and other volatile organic 

compounds and plasticizers, including 

phthalates) commonly found in higher 

concentrations in the temporary housing 

units compared with other types of 

housing. 

In the study, a 1:1 ratio of exposed 

and unexposed children age 5–17 years 

will be recruited. Children who resided 

in temporary housing units will be 

categorized into the ‘‘exposed’’ group 

and children who did not reside in 

temporary housing units will be 

categorized into the ‘‘unexposed’’ group. 

A screening questionnaire will be used 

to assess eligibility and exposure to 

temporary housing units. The screening 

questionnaire will be conducted with 

one adult resident of each selected 

household. Based on responses to the 

screening questions, one eligible child 

will be selected for the study from each 

participating household. To obtain the 

desired sample size, we plan to screen 

2,500 households in order to identify 

700 eligible children. Of these, it is 

expected that 80%, or 560 children, will 

agree to participate in the study. 

The Feasibility Study will involve a 

baseline and a 6-month follow-up 

assessment for each participant. The 

baseline assessment will include a 

health questionnaire, clinical 

assessment including biological sample 

collection, and environmental exposure 

measurement. The environmental 

exposure assessment will be collecting 

biomarkers of exposure and measuring 

exposures to environmental pollutants 

using personal and indoor sampling 

devices over a 7-day period. In the 6- 

month follow-up assessment, a shorter 

version of the health questionnaire and 

the same clinical and environmental 

exposure assessments will be 

conducted. 

Accounting for a 10% loss to followup, the sample size for the 6-month 

follow-up assessment is projected to be 

504 children. If a determination is made 

to conduct the Full Study, these 504 

children will be part of the Full Study 

and continue to participate in the rest of 

five follow-up assessments occurring at 

9-month intervals. 

There is no cost to the participants 

except their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Type of 

instrument 

Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response (in 

hours) 

Total burden 

(in hours) 

Household member 18 years or older .......... Eligibility Screener ................ 2,500 1 10/60 417 

Children ages 5–17 ...................................... Baseline Assessment ........... 560 1 1.25 700 

Parents of children ages 5–17 ..................... Baseline Assessment ........... 560 1 1.5 840 

Children ages 5-–17 ..................................... 6-Month Follow-up Assessment.504 1 50/60 420 

Parents of children ages 5–17 ..................... 6–Month Follow-up Assessment.504 1 1.25 630 

Total ....................................................... 3,007 

Dated: November 9, 2010. 

Carol E. Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–28787 Filed 11–15–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60-Day–11–0338] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 or send 

comments to Carol E. Walker, CDC 

Acting Reports Clearance Officer, 1600 

Clifton Road, MS D–74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Annual Submission of the Ingredients 

Added to, and the Quantity of Nicotine 

Contained in, Smokeless Tobacco 

Manufactured, Imported, or Packaged in 

the U.S. (OMB No. 0920–0338, exp. 4/ 

30/2011)—Extension—National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

The oral use of smokeless tobacco 

(SLT) products represents a significant 

health risk. Smokeless tobacco products 

contain carcinogens which can cause 

cancer and a number of non-cancerous 

mstockstill on DSKH9S0YB1PROD with NOTICES

70008 Federal Register / Vol. 75, No. 220 / Tuesday, November 16, 2010 / Notices 

oral conditions, as well as leading to 

nicotine addiction and dependence. 

Furthermore, SLT use is not a safe 

substitute for cigarette smoking. 

Adolescents who use smokeless tobacco 

are more likely to become cigarette 

smokers. 

The Centers for Disease Control and 

Prevention (CDC), Office on Smoking 

and Health (OSH), has primary 

responsibility for the Department of 

Health and Human Services (HHS) 

smoking and health program. HHS’s 

overall goal is to reduce death and 

disability resulting from the use of 

smokeless tobacco products and other 

forms of tobacco through programs of 

information, education and research. 

The Comprehensive Smokeless 

Tobacco Health Education Act of 1986 

(CSTHEA, 15 U.S.C. 4401 et seq., Pub. 

L. 99–252) requires each person who 

manufactures, packages, or imports 

smokeless tobacco products to provide 

the Secretary of Health and Human 

Services (HHS) with a list of ingredients 

added to tobacco in the manufacture of 

smokeless tobacco products. CSTHEA 

further requires submission of the 

quantity of nicotine contained in each 

smokeless tobacco product. Finally, the 

legislation authorizes HHS to undertake 

research, and to report to Congress (as 

deemed appropriate) discussing the 

health effects of these ingredients. 

HHS has delegated responsibility for 

implementing the required information 

collection to CDC’s Office on Smoking 

and Health. Respondents are not 

required to submit specific forms; 

however, they are required to meet 

reporting guidelines and to submit the 

ingredient report by chemical name and 

Chemical Abstract Service (CAS) 

Registration Number, consistent with 

accepted reporting practices for other 

companies that are required to report 

ingredients added to other consumer 

products. Typically, respondents submit 

a summary report to CDC with the 

ingredient information for multiple 

products, or a statement that there are 

no changes to their previously 

submitted ingredient report. 

Respondents may submit the required 

information to CDC through a 

designated representative. 

Ingredient reports for new SLT 

products are due at the time of first 

importation. Thereafter, ingredient 

reports are due annually on March 31. 

Information is submitted to OSH by 

mailing a written report on the 

respondent’s letterhead, by CD, threeinch floppy disk, or thumb drive. 

Electronic mail submissions are not 

accepted. Upon receipt and verification 

of the annual nicotine and ingredient 

report, OSH issues a Certificate of 

Compliance to the respondent. 

There are no costs to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Smokeless Tobacco Manufacturers, Packagers, and Importers.SLT Nicotine and Ingredient 

and Report.

11 1 1,713 18,843 

Dated: November 9, 2010. 

Carol E. Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–28786 Filed 11–15–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Office of Community Services 

(OCS) Community Economic 

Development (CED) and Job 

Opportunities for Low-Income 

Individuals (JOLI) Standard Reporting 

Format. 

OMB No.: New Collection. 

Description: The Office of Community 

Services (OCS) is collecting key 

information about projects funded 

through the Community Economic 

Development (CED) and Job 

Opportunities for Low-Income 

Individuals (JOLI) programs. The 

legislative requirement for these two 

programs is in Title IV of the 

Community Opportunities, 

Accountability and Training and 

Educational Services Act (COATS 

Human Services Reauthorization Act) of 

October 27, 1998, Public Law 105–285, 

section 680(b) as amended. The 

Performance Progress Report (PPR) is a 

new proposed reporting format that will 

collect information concerning the 

outcomes and management of CED and 

JOLI projects. OCS will use the data to 

critically review the overall design and 

effectiveness of each program. 

The PPR will be administered to all 

active grantees of the CED and JOLI 

programs. Grantees will be required to 

use this reporting tool for their 

semiannual reports. The majority of the 

questions in this tool were adapted from 

a previously approved questionnaire, 

Office of Management and Budget 

(OMB) Control Number: 0970–0317. 

Questions were also adapted to the 

OMB-approved reporting format of the 

PPR, specifically forms SF–PPR, SF– 

PPR–A, SF–PPR–B, and SF–PPR–E. 

Additional changes were made to 

improve the clarity and quality of the 

data and to eliminate unnecessary 

questions. The PPR will replace both the 

annual questionnaire and the current 

semi-annual reporting format, which 

will result in an overall reduction in 

burden for the grantees while 

significantly improving the quality of 

the data collected by OCS. 

Respondents: Current CED and JOLI 

grantees. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

hours per 

response 

Total 

burden 

hours 

Questionnaire for current OCS–JOLI grantees ............................................... 40 2 1.50 120 

Questionnaire for current OCS–CED grantees ............................................... 170 2 1.50 510 

mstockstill on DSKH9S0YB1PROD with NOTICES